News
Advertisement
Advertisement
Advertisement
Protecting Subjects: The IRBs Next Steps
SITES : Incorporating Standard of Care in Study Budgets Benefits of CTMS at the Investigative Site Also in this issue : FDA Transparency Efforts to Impact Research, Survey Assesses Europe?s Clinical Trials Directive, Tapping into the Potential of Pharmacists, Biosimilars Make Headway in the U.S.
Updates on Osteoporosis including Amgen and Prolia trials.
Act cover
Do Sites Prefer a Sponsor Company or CRO to Run Their Clinical Trial?
Industry news focusing on the people and organizations who work in the clinical trials profession.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
